The differential gene expression of Notch receptors in primary and metastatic epithelial ovarian cancer sites
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Purpose of Investigation: Notch signaling belongs among the candidate pathways for targeted therapies in ovarian cancer. While Notch 3 and Notch 1 overexpression has already been confirmed in ovarian carcinomas compared to their benign counterparts, the expression in metastatic sites is still not well known. The aim of the current study was to compare the relative expression of the four Notch gene receptors between primary and metastatic sites of ovarian carcinomas. Materials and Methods: Seventeen paired couples of tissues, from primary and metastatic sites of epithelial ovarian cancer, were collected during the cytoreductive surgery. For the study of the gene expression Real-Time Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was used. The analysis of the results was performed with the Comparative C T Method (ΔΔCt Method). Results: Notch 3 and 2 were overexpressed compared to Notch 1 and 4 in both primary and metastatic sites. Notch 3 showed the highest differential expression, yet none of the four Notch genes reached statistical significance due to the differences between different samples. Conclusions: The lack of statistical difference in the expression of all four genes between primary and metastatic sites of epithelial ovarian cancer, potentially predicts same treatment response in all intrabdominal tumours and render Notch pathway a suitable and promising candidate for targeted therapies. The high heterogeneity in the expression between the samples, highlights even more the need of personalized therapies. Further studies should include more patients, examine the absolute expression, extend to all histological types, and focus on the Notch intracellular domain expression.
Authors and Affiliations
I. C. Kotsopoulos, A. Papanikolaou, K. T. Papazisis, P. Touplikioti, D. Tsolakidis, A. F. Lambropoulos, B. C. Tarlatzis
Keywords
Related Articles
- EP ID EP663035
- DOI 10.12892/ejgo4354.2019
- Views 85
- Downloads 0
Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding
Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additio...
Complementary and alternative medicine. Use and challenges among gynaecological cancer patients in Nigeria: experiences in a tertiary health institution - preliminary results
Background: Cancer patients have keyed into increasing global interest in the use of Complementary and Alternative Medicine (CAM). There are few studies on CAM use among gynaecological cancer patients in our environment....
The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro
Purpose of investigation: The pleiotropic factor Y-box binding protein-1 (YB-1) is clinically correlated with breast cancer patients’ poor outcome. Due to the intereference of YB-1 with the estrogen receptor, the authors...
Risk of cervical cancer and squamous intraepithelial lesions according to human papillomavirus high-risk serotypes detected by qualitative real-time in vitro PCR
Purpose of investigation: To establish the relationship between high-risk human papillomavirus (hrHPV) serotypes and the odds of developing cervical intraepithelial lesions. Material and Methods: Retrospective cohort stu...
High immunoexpression of progesterone-induced blocking factor (PIBF) in endometrial cancer
Purpose of Investigation: This study aims to investigate PIBF expression levels in normal, hyperplastic, and endometrioid adenocarcinoma paraffin blocks. The purpose of this study is to determine the PIBF expression leve...